Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Carcinoma Cell
100%
Radioresistance
100%
Downregulation
100%
Phosphotransferase
100%
Kinase
100%
Programmed Cell Death
50%
Western Blot
50%
Wild Type
50%
Histone
50%
P53
50%
Mitogen
50%
Antisense
50%
Cycline
50%
Survival Rate
50%
Protein Family
50%
Carcinoma Cell Line
50%
Keyphrases
Survivin Expression
100%
Survivin
100%
Radiosensitivity
100%
Human Epidermoid Carcinoma Cells
100%
Radiosensitizing Effect
33%
Radiotherapy
16%
Histone Deacetylase Inhibitor (HDACi)
16%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
16%
Wild-type p53
16%
Inhibitor of Apoptosis Proteins
16%
Western Blot Analysis
16%
Patient Tumor
16%
Antisense
16%
Patient Prognosis
16%
Human Cancer
16%
Adenoviral
16%
Radiosensitization
16%
Resistance to Chemotherapy
16%
Radioresistant
16%
Clonogenic Survival
16%
PD98059
16%
Mitogen-activated Protein Kinase Inhibitor
16%
Trichostatin A
16%
A431
16%
A431 Cells
16%
Survival Curve Analysis
16%
Tumor Resistance
16%
Relative Ability
16%
Purvalanol
16%
Carcinoma Cell Line
16%
Biochemistry, Genetics and Molecular Biology
Downregulation
100%
Radiosensitivity
100%
Survivin
100%
A431 Cells
20%
P53
10%
Histone Deacetylase
10%
Wild Type
10%
extracellular signal regulated kinase
10%
Western Blot
10%
Antisense
10%
Survival Rate
10%
Cyclin-Dependent Kinase
10%
Protein Family
10%
Inhibitor of Apoptosis
10%
Trichostatin A
10%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Survivin
100%
Malignant Neoplasm
10%
Western Blot
10%
Histone Deacetylase Inhibitor
10%
Protein P53
10%
Survival Rate
10%
Cyclin Dependent Kinase Inhibitor
10%
2 (2 Amino 3 Methoxyphenyl)chromone
10%
Mitogen Activated Protein Kinase Inhibitor
10%
Trichostatin A
10%
Inhibitor of Apoptosis Protein
10%
Tumor Resistance
10%
Purvalanol A
10%
Chemotherapy Regimen
10%